Third Party Royalties. If Licensee or its Affiliates is required to pay royalties to any Third Party that are, in the opinion of an independent patent attorney (reasonably acceptable to both parties), necessary to practice the inventions claimed in the Licensed IP, then Licensee shall have the right to credit such Third Party royalty payments against the royalties owing to Licensor under Section 4.2.1; provided, however, that the foregoing credits shall not reduce the amount of the royalties payable to Licensor under Section 4.2.1 above by more than fifty percent (50%).
Appears in 5 contracts
Sources: Exclusive License and Sublicense Agreement (VistaGen Therapeutics, Inc.), Exclusive License and Sublicense Agreement (VistaGen Therapeutics, Inc.), License Agreement (VistaGen Therapeutics, Inc.)
Third Party Royalties. If Licensee or its Affiliates is required to pay royalties to any Third Party that are, in the opinion of an independent patent attorney (reasonably acceptable to both parties), necessary to practice the inventions claimed in the Licensed IP, then Licensee shall have the right to credit such Third Party royalty payments against the royalties owing to Licensor under Section 4.2.14.2.3; provided, however, that the foregoing credits shall not reduce the amount of the royalties payable to Licensor under Section 4.2.1 4.2.3 above by more than fifty percent (50%).
Appears in 2 contracts
Sources: Exclusive License and Sublicense Agreement (VistaGen Therapeutics, Inc.), Exclusive License and Sublicense Agreement (VistaGen Therapeutics, Inc.)
Third Party Royalties. If Licensee or its Affiliates is required to pay royalties to any Third Party that are, in the opinion of an independent patent attorney (reasonably acceptable to both parties), necessary to practice the inventions claimed in the Licensed IP, then Licensee shall have the right to credit such Third Party royalty payments against the royalties owing to Licensor under Section 4.2.1; provided4.2.3;provided, however, that the foregoing credits shall not reduce the amount of the royalties payable to Licensor under Section 4.2.1 4.2.3 above by more than fifty percent (50%).
Appears in 2 contracts
Sources: Exclusive License and Sublicense Agreement (VistaGen Therapeutics, Inc.), Exclusive License and Sublicense Agreement (VistaGen Therapeutics, Inc.)
Third Party Royalties. If Licensee or its Affiliates is Is required to pay royalties to any Third Party that are, in the opinion of an independent Independent patent attorney (reasonably acceptable to both parties), necessary to practice the inventions claimed in the Licensed IP, then Licensee shall have the right to credit such Third Party royalty payments against the royalties owing to Licensor under Section 4.2.1; provided, 4.2.3;provided. however, . that the foregoing credits shall not reduce the amount of the royalties payable to Licensor under Section 4.2.1 4.2.3 above by more than fifty percent (50%).
Appears in 2 contracts
Sources: Exclusive License and Sublicense Agreement (VistaGen Therapeutics, Inc.), Exclusive License and Sublicense Agreement (VistaGen Therapeutics, Inc.)
Third Party Royalties. If Licensee or its Affiliates is required to pay royalties to any Third Party that are, in the opinion of an independent patent attorney (reasonably acceptable to both parties), necessary to practice the inventions claimed in the Licensed IP, then Licensee shall have the right to credit such Third Party royalty payments against the royalties owing to Licensor under Section 4.2.1; provided, however, that the foregoing credits shall not reduce the amount of the royalties payable to Licensor under Section 4.2.1 above by more than fifty percent (50%). -6- 4.
Appears in 1 contract
Sources: License Agreement
Third Party Royalties. If Licensee or its Affiliates is required to pay royalties to any Third Party that are, in the opinion of an independent patent attorney (reasonably acceptable to both parties), necessary to practice the inventions claimed in the Licensed IP, then Licensee shall have the right to credit such Third Party royalty payments against the royalties owing to Licensor under Section 4.2.14.2(a); provided, however, that the foregoing credits shall not reduce the amount of the royalties payable to Licensor under Section 4.2.1 4.2(a) above by more than fifty percent (50%).
Appears in 1 contract
Sources: Patent License Amendment Agreement (VistaGen Therapeutics, Inc.)